(Q46062368)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Giuseppe Sacco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Bigioni Mario

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Giuseppe Lopez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Stefano Manzini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Carlo Alberto Maggi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

5-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

166-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Effects of angiotensin-converting enzyme inhibitor on delayed-onset doxorubicin-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Reducing cardiovascular risk by blockade of the renin-angiotensin-aldosterone system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Antioxidant and cardioprotective properties of the sulphydryl angiotensin-converting enzyme inhibitor zofenopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Effect of Sulfhydryl and non-Sulfhydryl Angiotensin-Converting Enzyme Inhibitors on Endothelial Function in Essential Hypertensive Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Induction of antioxidants by adriamycin in mouse heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

An angiotensin-converting enzyme inhibitor protects against doxorubicin-induced impairment of calcium handling in neonatal rat cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Role of Ca2+-activated K+ channels in the protective effect of ACE inhibition against ischemic myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Standardization of a fluorimetric assay for the determination of tissue angiotensin-converting enzyme activity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Etiology of sarcoplasmic reticulum calcium release channel lesions in doxorubicin-induced cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Anthracyclines and the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: predictiveness and pitfalls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

An improved fluorometric assay of rat serum and plasma converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Prevention of doxorubicin (adriamycin)-induced cardiomyopathy by simultaneous administration of angiotensin-converting enzyme inhibitor assessed by acoustic densitometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

Relationship between doxorubicin-induced ECG changes and myocardial alterations in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.001

10.1016/J.VPH.2009.01.001

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344651%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference